In Spain, approximately 13.8 percent of people over 18 suffer from type 2 diabetes, which translates into more than 5.3 million patients, as highlighted by the Spanish Foundation for Diabetes, who has highlightedThe "need" to promote knowledge about new treatments among primary care doctors with the aim of improving the patient's quality of life, since currently most of these cases are treated in this area.

In this sense, Dr. Flora López Simarro, coordinator of the Diabetes Working Group of the Spanish Society of Primary Care Physicians (Semergen), stressed that new families of drugs have been introduced that have different mechanisms of action from each other and withLimitations of use depending on the characteristics of each patient.

Diagnostic recommendations for diabetes

As a consequence, the Semergen Diabetes Working Group has updated the 'DOC DOC in Diabetes ’.Diagnostic recommendations on clinical management and therapeutic approach to these patients have been introduced.Among the key issues that have been incorporated, the presentation of the marketed insulins, the role of new insulins, the beginning of insulinization, insulin intensification guidelines, insulinization in special situations, and the therapeutic education of insulinization, are highlighted.

Llisterri: "Good practices are synonymous with early diagnosis, monitoring, effective approach and reduction of long -term complications"

"Good practices are synonymous with early diagnosis, monitoring, effective approach and reduction of long -term complications. Hence the importance of implementing training and research actions, such as the Doc Diabetes Semergen, which help the family doctor and family doctorThey are linked to the chronic complications of diabetes, "concluded Dr. José Luis Llisterri, president of Semergen.

Therapeutic alternatives in diabetes

Likewise, Semergen has developed a training cycle of workshops nationwide in order to deepen the sections of the document referring to insulinization.This is intended to update the knowledge of primary care doctors on the health management of patients with type 2 diabetes, to know which therapeutic alternatives have to be implemented in each patient based on their individualized characteristics.

This project, which began on March 28 in Burgos, is carrying out new appointments in other Spanish cities, which will be taught by members of the Semergen Diabetes Working Group.Thus, these training workshops are based on the real practice of the consultations of family doctors in primary care and "will be developed in such a way that attendees can be part of them," as Javier Mediavilla, a member of the group of group of the group ofSemergen diabetes work.

In this way, the patient's follow -up will be addressed over time, special situations, therapeutic education and practical recommendations to improve the quality of life of these patients.